Ameritas Investment Partners’s Select Medical SEM Stock Holding History

Ameritas Investment Partners’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Hold	8,728	–	–	﹤0.01%	1612
2026 Q1	$142K	Hold	8,728	–	–	﹤0.01%	1470
2025 Q4	$130K	Sell	8,728 -616	-7%	-$8.71K	﹤0.01%	1538
2025 Q3	$120K	Sell	9,344 -1,623	-15%	-$21.6K	﹤0.01%	1569
2025 Q2	$166K	Hold	10,967	–	–	0.01%	1412
2025 Q1	$183K	Hold	10,967	–	–	0.01%	1313
2024 Q4	$207K	Sell	10,967 -9,388	-46%	-$181K	0.01%	1305
2024 Q3	$382K	Buy	20,355 +1,099	+6%	+$21.1K	0.01%	947
2024 Q2	$364K	Sell	19,256 -724	-4%	-$12.3K	0.01%	924
2024 Q1	$325K	Hold	19,980	–	–	0.01%	996
2023 Q4	$253K	Buy	19,980 +802	+4%	+$10.1K	0.01%	1123
2023 Q3	$261K	Buy	19,178 +3,239	+20%	+$50K	0.01%	1021
2023 Q2	$274K	Buy	15,939 +902	+6%	+$14K	0.01%	966
2023 Q1	$209K	Hold	15,037	–	–	0.01%	1068
2022 Q4	$233K	Hold	15,037	–	–	0.01%	1045
2022 Q3	$179K	Hold	15,037	–	–	0.01%	1117
2022 Q2	$191K	Sell	15,037 -685	-4%	-$8.79K	0.01%	1092
2022 Q1	$203K	Hold	15,722	–	–	0.01%	1179
2021 Q4	$249K	Hold	15,722	–	–	0.01%	1094
2021 Q3	$306K	Sell	15,722 -676	-4%	-$13.4K	0.01%	943
2021 Q2	$373K	Hold	16,398	–	–	0.01%	873
2021 Q1	$301K	Sell	16,398 -488	-3%	-$8K	0.01%	942
2020 Q4	$252K	Sell	16,886 -681	-4%	-$8.89K	0.01%	1015
2020 Q3	$197K	Sell	17,567 -770	-4%	-$7.58K	0.01%	1036
2020 Q2	$146K	Hold	18,337	–	–	0.01%	1188
2020 Q1	$148K	Buy	18,337 +523	+3%	+$6.21K	0.01%	1056
2019 Q4	$224K	Buy	17,814 +704	+4%	+$7.58K	0.01%	1027
2019 Q3	$153K	Hold	17,110	–	–	0.01%	1209
2019 Q2	$146K	Hold	17,110	–	–	0.01%	1261
2019 Q1	$130K	Hold	17,110	–	–	0.01%	1309
2018 Q4	$142K	Hold	17,110	–	–	0.01%	1159
2018 Q3	$170K	Hold	17,110	–	–	0.01%	1195
2018 Q2	$167K	Hold	17,110	–	–	0.01%	1181
2018 Q1	$159K	Hold	17,110	–	–	0.01%	1204
2017 Q4	$163K	Hold	17,110	–	–	0.01%	1205
2017 Q3	$171K	Hold	17,110	–	–	0.01%	1145
2017 Q2	$142K	Hold	17,110	–	–	0.01%	1243
2017 Q1	$123K	Buy	+17,110	New	+$124K	0.01%	1311

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Ameritas Investment Partners's SEM Position: Q2 2026 in Review

Ameritas Investment Partners held its Select Medical (SEM) position steady in Q2 2026 at 8,728 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Ameritas Investment Partners first reported a position in SEM in Q1 2017 and has held it in 38 quarters since. The position peaked at $382K in Q3 2024. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Ameritas Investment Partners held 8,728 shares of Select Medical worth $144K as of Q2 2026.
Ameritas Investment Partners left its Select Medical share count unchanged in Q2 2026.
Select Medical made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1612 holding.
Ameritas Investment Partners first reported a position in Select Medical in Q1 2017 and has held it in 38 quarters since.
Ameritas Investment Partners's Select Medical position peaked at $382K in Q3 2024.
239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.